Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon D O Lowe

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Pathophysiology of Haemostasis and Thrombosis|September 26, 2003
Hormone replacement therapy: prothrombotic vs. protective effectsGordon D O Lowe
Women'S Health (London, England)|October 7, 2009
Update on the cardiovascular risks of hormone replacement therapyGordon D O Lowe
British Journal of Haematology|April 29, 2006
Can haematological tests predict cardiovascular risk? The 2005 Kettle LectureGordon D O Lowe
Clinical Chemistry|March 30, 2010
Fibrinogen assays for cardiovascular risk assessmentGordon D O Lowe
Seminars in Vascular Medicine|October 14, 2005
The need for risk factor assessment in atherothrombotic vascular diseaseGordon D O Lowe, John Danesh
Current Atherosclerosis Reports|August 12, 2006
C-reactive protein and cardiovascular disease: weighing the evidenceGordon D O Lowe, Mark B Pepys
Annals of Clinical Biochemistry|December 14, 2004
Plasma fibrinogenGordon D O Lowe, Ann Rumley, Ian J Mackie
BMJ (Clinical Research Ed.)|January 24, 2004
Britain's failure to tackle research misconduct: UK bodies are now working together to set up panel on misconductGordon D O Lowe, Gordon D Murray, Niall D Finlayson
Seminars in Vascular Medicine|October 14, 2005
Hemostatic and rheological variables and risk of cardiovascular diseaseGordon D O Lowe, Ann Rumley, Peter H Whincup, et al.
Lancet (London, England)|August 23, 2003
Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?Gordon D O Lowe, Peter A G Sandercock, Frits R Rosendaal
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Pathophysiology of Haemostasis and Thrombosis|September 26, 2003
Hormone replacement therapy: prothrombotic vs. protective effectsGordon D O Lowe
Women'S Health (London, England)|October 7, 2009
Update on the cardiovascular risks of hormone replacement therapyGordon D O Lowe
British Journal of Haematology|April 29, 2006
Can haematological tests predict cardiovascular risk? The 2005 Kettle LectureGordon D O Lowe
Clinical Chemistry|March 30, 2010
Fibrinogen assays for cardiovascular risk assessmentGordon D O Lowe
Seminars in Vascular Medicine|October 14, 2005
The need for risk factor assessment in atherothrombotic vascular diseaseGordon D O Lowe, John Danesh
Current Atherosclerosis Reports|August 12, 2006
C-reactive protein and cardiovascular disease: weighing the evidenceGordon D O Lowe, Mark B Pepys
Annals of Clinical Biochemistry|December 14, 2004
Plasma fibrinogenGordon D O Lowe, Ann Rumley, Ian J Mackie
BMJ (Clinical Research Ed.)|January 24, 2004
Britain's failure to tackle research misconduct: UK bodies are now working together to set up panel on misconductGordon D O Lowe, Gordon D Murray, Niall D Finlayson
Seminars in Vascular Medicine|October 14, 2005
Hemostatic and rheological variables and risk of cardiovascular diseaseGordon D O Lowe, Ann Rumley, Peter H Whincup, et al.
Lancet (London, England)|August 23, 2003
Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?Gordon D O Lowe, Peter A G Sandercock, Frits R Rosendaal
Pageof 13